Dapagliflozin versus empagliflozin in patients with chronic kidney disease.

Alnsasra, Hilmi; Tsaban, Gal; Solomon, Adam; Khalil, Fouad; Aboalhasan, Enis; Azab, Abed N; Azuri, Joseph; Hammerman, Ariel; Arbel, Ronen.

Afiliação

Alnsasra H; Department of Cardiology, Soroka University Medical Center, Beersheba, Israel.
Tsaban G; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.
Solomon A; Department of Cardiology, Soroka University Medical Center, Beersheba, Israel.
Khalil F; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.
Aboalhasan E; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.
Azab AN; Sanford School of Medicine, University of South Dakota, Vermillion, SD, United States.
Azuri J; Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel.
Hammerman A; Department of Cardiology, Soroka University Medical Center, Beersheba, Israel.
Arbel R; Department of Nursing, Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.